These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12438295)

  • 1. Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Ellison KE; Hafley GE; Hickey K; Kellen J; Coromilas J; Stein KM; Lee KL; Buxton AE;
    Circulation; 2002 Nov; 106(21):2694-9. PubMed ID: 12438295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial.
    Buxton AE; Lee KL; Hafley GE; Wyse DG; Fisher JD; Lehmann MH; Pires LA; Gold MR; Packer DL; Josephson ME; Prystowsky EN; Talajic MR;
    Circulation; 2002 Nov; 106(19):2466-72. PubMed ID: 12417544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial.
    Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE;
    Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).
    Fisher JD; Buxton AE; Lee KL; Packer DL; Echt DS; Denes P; Lehmann MH; DiMarco JP; Roy D; Hafley GE;
    Am J Cardiol; 2007 Jul; 100(1):76-83. PubMed ID: 17599445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.
    Buxton AE; Lee KL; Hafley GE; Pires LA; Fisher JD; Gold MR; Josephson ME; Lehmann MH; Prystowsky EN;
    J Am Coll Cardiol; 2007 Sep; 50(12):1150-7. PubMed ID: 17868806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks.
    Russo AM; Hafley GE; Lee KL; Stamato NJ; Lehmann MH; Page RL; Kus T; Buxton AE;
    Circulation; 2003 Jul; 108(1):67-72. PubMed ID: 12821551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial.
    Russo AM; Stamato NJ; Lehmann MH; Hafley GE; Lee KL; Pieper K; Buxton AE;
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):993-8. PubMed ID: 15363069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
    Prystowsky EN; Nisam S
    Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis.
    Wyse DG; Talajic M; Hafley GE; Buxton AE; Mitchell LB; Kus TK; Packer DL; Kou WH; Lemery R; Santucci P; Grimes D; Hickey K; Stevens C; Singh SN
    J Am Coll Cardiol; 2001 Aug; 38(2):344-51. PubMed ID: 11499722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prevention of sudden cardiac death with implantable cardioverter defibrillators: lessons learned from MADIT and MUSTT.
    Gold MR; Nisam S;
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1981-5. PubMed ID: 11139972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MUSTT study: evaluating testing and treatment.
    Klein HU; Reek S
    J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():45-50. PubMed ID: 10590488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design.
    Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Mangiameli S; Montenero A; Pedretti R; Salerno J; Sermasi S
    Am J Cardiol; 1999 Mar; 83(5B):104D-111D. PubMed ID: 10089851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsustained ventricular tachycardia in coronary artery disease: relation to inducible sustained ventricular tachycardia. MUSTT Investigators.
    Buxton AE; Lee KL; DiCarlo L; Echt DS; Fisher JD; Greer GS; Josephson ME; Packer D; Prystowsky EN; Talajíc M
    Ann Intern Med; 1996 Jul; 125(1):35-9. PubMed ID: 8644986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in inducibility and prognosis of in-hospital versus out-of-hospital identified nonsustained ventricular tachycardia in patients with coronary artery disease: clinical and trial design implications.
    Pires LA; Lehmann MH; Buxton AE; Hafley GE; Lee KL;
    J Am Coll Cardiol; 2001 Oct; 38(4):1156-62. PubMed ID: 11583897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.